Monoaminergic system and depression

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Cell and Tissue Research

• Publication date

  2019-01-10

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00441-018-2978-8PMID 30627806
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.

  2018cited by this paper
• Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review

  2018cited by this paper
• Prevalence of Depression in the Community from 30 Countries between 1994 and 2014

  2018cited by this paper
• Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies.

  2017cited by this paper
• The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis

  2017cited by this paper
• An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms

  2017cited by this paper
• Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

  2016cited by this paper
• The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder

  2016cited by this paper
• Out of the shadows : making mental health a global development priority

  2016cited by this paper
• The noradrenergic paradox: implications in the management of depression and anxiety

  2016cited by this paper
• Antidepressant drug development: Focus on triple monoamine reuptake inhibition

  2015cited by this paper
• Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data.

  2015cited by this paper
• Global, regional, and national incidence, prevalence, and YLDs for 301 acute and chronic diseases and injuries for 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

  2015cited by this paper
• Mental health: A world of depression

  2014cited by this paper
• The Integrative Management of Treatment-Resistant Depression: A Comprehensive Review and Perspectives

  2014cited by this paper
• Role of Lithium Augmentation in the Management of Major Depressive Disorder

  2014cited by this paper
• Early responses to deep brain stimulation in depression are modulated by anti-inflammatory drugs

  2014cited by this paper
• Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010

  2013cited by this paper
• Second-generation antipsychotics in the treatment of major depressive disorder: current evidence

  2013cited by this paper
• Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature

  2012cited by this paper
• The Efficacy and Tolerability of Bupropion in the Treatment of Major Depressive Disorder

  2011cited by this paper
• Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression

  2010cited by this paper
• Agomelatine, the first melatonergic antidepressant: discovery, characterization and development

  2010cited by this paper
• Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today.

  2009cited by this paper
• Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials.

  2009cited by this paper
• Opiates as antidepressants.

  2009cited by this paper
• The STAR*D trial: revealing the need for better treatments.

  2009cited by this paper
• The molecular neurobiology of depression

  2008cited by this paper
• A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.

  2006cited by this paper
• Basic mechanisms of augmentation of antidepressant effects with thyroid hormone.

  2006cited by this paper
• Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

  2006cited by this paper
• Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

  2006cited by this paper
• Medication augmentation after the failure of SSRIs for depression.

  2006cited by this paper
• Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis.

  2006cited by this paper
• Is there a delay in the antidepressant effect? A meta-analysis.

  2005cited by this paper
• Depression: management of depression in primary and secondary care

  2005cited by this paper
• Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trials.

  2004cited by this paper
• The therapeutic role of 5-HT1A and 5-HT2A receptors in depression.

  2004cited by this paper
• Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis.

  2003cited by this paper
• Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

  2001cited by this paper
• Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature.

  2001cited by this paper
• Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.

  1997cited by this paper
• Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis.

  1996cited by this paper
• Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

  1996cited by this paper
• Current advances and trends in the treatment of depression.

  1994cited by this paper
• Tryptophan in the treatment of depression.

  1967cited by this paper
• The catecholamine hypothesis of affective disorders: a review of supporting evidence.

  1965cited by this paper
• [On the pharmacology of tofranil (N-(3-dimethylaminopropyl)-iminodibenzyl hydrochloride].

  1959cited by this paper
• A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer.

  1957cited by this paper
• [Treatment of depressive states with an iminodibenzyl derivative (G 22355)].

  1957cited by this paper
• Depressive states during Rauwolfia therapy for arterial hypertension; a report of 30 cases.

  1956cited by this paper

• Involvement of Serotonergic and Dopaminergic Systems in Aloysia gratissima var. gratissima: Antidepressant-like Effect, UPLC-DAD-MS Chemical Characterization, and Computational Evidence.

  2026cites this paper
• Aquaporin-4 Dysfunction in Depression: From Pathogenic Mechanisms to Novel Therapeutic Targeting

  2026cites this paper
• Unveiling the promising pharmacological and molecular insights into Ruppia maritima: Natural source of antidepressant, sedative, and antidiarrheal agents

  2026cites this paper
• Neurochemical and Energetic Alterations in Depression: A Narrative Review of Potential PET Biomarkers

  2026cites this paper
• Fatty acid binding proteins and their involvement in anxiety and mood disorders.

  2025cites this paper
• Habits and vulnerability or resilience to stress - Impact on depressive disorders.

  2025cites this paper
• Advancing Antidepressive Agents: Drug Discovery and Polymer-Based Drug Delivery Systems for Improved Treatment Outcome

  2025cites this paper
• Administration of chiglitazar reverses chronic stress-induced depressive-like symptoms in mice via activation of hippocampal PPARα and BDNF

  2025cites this paper
• Pathogenesis of HIV-associated depression: contributing factors and underlying mechanisms

  2025cites this paper
• Decoding Depression: Insights into Molecular Biomarkers and Neuroimaging of Depression

  2025cites this paper
• Age-related abnormalities in brain functional and molecular neuroimaging signatures in first-episode depression.

  2025cites this paper
• Association between cardiometabolic index and depression in a stroke population: a cross-sectional study of NHANES

  2025cites this paper
• Social network site addiction, sleep quality, depression and adolescent difficulty describing feelings: a moderated mediation model

  2025cites this paper
• Cichorium intybus L. Oligo-Polysaccharides (CIO) Exerts Antianxiety and Antidepressant Effects on Mice Experiencing Behavioral Despair and Chronic Unpredicted Mild Stress

  2025cites this paper
• Assessment of the Therapeutic Potential of Hesperidin and Quercetin Nanoparticles on Oxidative Stress, Enzyme Activities, Trophic Factors, and Monoamines in an Animal Model of Depression

  2025cites this paper
• Tea and Its Active Ingredients in Preventing and Alleviating Depression: A Comprehensive Review

  2025cites this paper
• Enhancing mood post-bariatric surgery: Associations of rosuvastatin with vitamin D, oxidative stress, and neurotransmitter-related outcomes in rats.

  2025cites this paper
• Glutamatergic Mechanisms Underlying the Antidepressant-Like Effects of 1-(Phenylselanyl)-2-(p-tolyl)indolizine in Mice.

  2025cites this paper
• Effects of Aerobic Exercises at Different Intensities on Sleep Quality in Individuals with Depression: A Systematic Review and Meta-Analysis

  2025influential citation
• Regulation of Cerebral BDNF, VEGF, and GluN2B Gene Expression and Cytokine Levels by Riparin A in a Murine Model of Depression

  2025cites this paper
• Serotonin 2A (5-HT2A) receptor as evolving biological target: function, structure, ligands and role in the therapy of neuropsychiatric diseases.

  2025cites this paper
• When the Stars Misfire: Astrocytic Dysfunctions in Major Depressive Disorder

  2025cites this paper
• nNOS-expressing neurons in the mPFC mediate depression-related behaviors in mice through pPVT-mPFC projections

  2025cites this paper
• Effects of acute treadmill running following administration of lipopolysaccharide on subsequent changes in microglial activation and depressive-like behavior in rats.

  2025cites this paper
• Jiannao Pills alleviate depression-like behavior in chronic unpredictable mild stress-induced mice through NF-κB/NLRP3 pathway

  2025cites this paper
• The Role of Vitamin D in the Management of Major Depressive Disorder: A Systematic Review

  2025cites this paper
• NLRP3 in the dorsal raphe nucleus manipulates the depressive-like behaviors.

  2025cites this paper
• Zhi-Zi-Chi decoction ameliorates depression-like behavior in chronic unpredictable mild stress-induced mice via the PI3K/AKT/mTOR signaling pathway.

  2025cites this paper
• Premenstrual syndrome: new insights into etiology and review of treatment methods

  2024cites this paper
• Dopaminergic Modulation and Computational ADMET Insights for the Antidepressant-like Effect of N-(3-(Phenylselanyl)prop-2-yn-1-yl)benzamide.

  2024cites this paper
• The impact of diabetes mellitus on the development of psychiatric and neurological disorders

  2024cites this paper
• Potential antidepressant effects of Traditional Chinese botanical drug formula Chaihu-Shugan-San and its active ingredients

  2024cites this paper
• A Comprehensive Review of the Pathophysiology of Depression

  2024cites this paper
• A magnetic beads-based ligand fishing method for rapid discovery of monoterpene indoles as monoamine oxidase A inhibitors from Hunteria zeylanica.

  2024cites this paper
• Perspectives on the impact of vortioxetine on the treatment armamentarium of major depressive disorder

  2024cites this paper
• Translational bioinformatics and data science for biomarker discovery in mental health: an analytical review

  2024influential citation
• Genetically encoded sensors for in vivo detection of neurochemicals relevant to depression

  2024cites this paper
• Review of research progress on intestinal microbiota based on metabolism and inflammation for depression

  2024cites this paper
• Down-regulation of MKP-1 in hippocampus protects against stress-induced depression-like behaviors and neuroinflammation

  2024cites this paper
• Cerebrolysin potentiates the antidepressant effect of lithium in a rat model of depression.

  2024cites this paper
• Design, Synthesis, and Activity Evaluation of Fluorine-Containing Scopolamine Analogues as Potential Antidepressants.

  2024cites this paper
• Why does malaise/fatigue occur? Underlying mechanisms and potential relevance to treatments in rheumatoid arthritis

  2024cites this paper
• Effect of a New Substance with Pyridoindole Structure on Adult Neurogenesis, Shape of Neurons, and Behavioral Outcomes in a Chronic Mild Stress Model in Rats

  2024cites this paper
• Molecular Mechanisms of Reelin in the Enteric Nervous System and the Microbiota–Gut–Brain Axis: Implications for Depression and Antidepressant Therapy

  2024cites this paper
• Brain-derived neurotrophic factor in the pathogenesis of comorbid coronary artery disease and depression: a review

  2024cites this paper
• Evidence for the contribution of vasopressin V1B receptors in the pathophysiology of depression.

  2024cites this paper
• Cafeteria Diet Abstinence Induces Depressive Behavior and Disrupts Endocannabinoid Signaling in Dopaminergic Areas: A Preclinical Study

  2024cites this paper
• Unravelling the neuroinflammatory links in depression: the potential of a lipopolysaccharide preclinical model

  2024cites this paper
• A New Augmentation Strategy against Depression Combining SSRIs and the N-terminal Fragment of Galanin (1-15)

  2024cites this paper
• Rehmannia glutinosa DC.-Lilium lancifolium Thunb. in the treatment of depression: a comprehensive review and perspectives

  2024cites this paper
• Prebiotic inulin alleviates anxiety and depression-like behavior in alcohol withdrawal mice by modulating the gut microbiota and 5-HT metabolism.

  2024cites this paper
• Genetic polymorphism involved in major depressive disorder: a systemic review and meta-analysis

  2024cites this paper
• Flavonoids against depression: a comprehensive review of literature

  2024cites this paper
• Antidiabetic, Antidepressant, Antiparkinson’s, Neuroprotective, and Antioxidant Potentials of Novel Schiff Base Derivatives of a Lichen Metabolite, Usnic Acid

  2024cites this paper
• The CB2-PKC pathway is involved in esketamine-induced anti-inflammation in BV-2 microglial cells exposed to lipopolysaccharides.

  2024cites this paper
• Kefir recovered depressive-like behaviour in CantonS lineage of Drosophila melanogaster exposed to chronic unpredictable mild stress protocol.

  2024cites this paper
• The glutamatergic system in the development of stress-induced depression

  2024cites this paper
• Impacts of Electroconvulsive Therapy on the Neurometabolic Activity in a Mice Model of Depression: An Ex Vivo 1H-[13C]-NMR Spectroscopy Study

  2024cites this paper
• The Neurodegenerative Hypothesis of Depression and the Influence of Antidepressant Medications.

  2024cites this paper
• Effect of Mucuna pruriens seed extract on depression-like behavior derived from mild traumatic brain injury in rats

  2024cites this paper
• Pyrrole: An Essential Framework in the Development of Therapeutic Agents and Insightful Analysis of Structure‐Active Relationships

  2024cites this paper
• Efficacy and safety of add-on sarcosine in patients with major depressive disorder: A randomized controlled trial.

  2024cites this paper
• "Inflamed" depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression.

  2024cites this paper
• Breakthroughs and challenges for generating brain network-based biomarkers of treatment response in depression

  2024cites this paper
• The antidepressant potential of (R)- (-)-Carvone involves antioxidant and monoaminergic mechanisms in mouse models

  2024cites this paper
• Study on the Mechanism of Gut Microbiota in the Pathogenetic Interaction Between Depression and Parkinson 's Disease.

  2024cites this paper
• Parvalbumin interneurons in human ventromedial prefrontal cortex: a comprehensive post-mortem study of myelination and perineuronal nets in neurotypical individuals and depressed suicides with and without a history of child abuse.

  2024cites this paper
• New insights into the involvement of serotonin and BDNF-TrkB signalling in cannabidiol's antidepressant effect.

  2024cites this paper
• Evaluation of New Approaches to Depression Treatment Using an Animal Model of Pharmacoresistant Depression

  2024cites this paper
• Cyclooxygenase-2 inhibitors alleviated depressive and anxious-like behaviors in mice exposed to lipopolysaccharide: Involvement of oxidative stress and neuroinflammation.

  2024cites this paper
• RNA methylations in depression, from pathological mechanism to therapeutic potential.

  2023cites this paper
• Differentiated HT22 cells as a novel model for in vitro screening of serotonin reuptake inhibitors

  2023cites this paper
• Neuroprotective Potentials of Flavonoids: Experimental Studies and Mechanisms of Action

  2023cites this paper
• Direct evidence for the involvement of intestinal reactive oxygen species in the progress of depression via the gut-brain axis.

  2023cites this paper
• Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review

  2023cites this paper
• C-Reactive Protein (CRP): A Potent Inflammation Biomarker in Psychiatric Disorders.

  2023cites this paper
• An Ensemble Classification Model for Depression Based on Wearable Device Sleep Data

  2023cites this paper
• Adaptogenic property of Asparagus racemosus: Future trends and prospects.

  2023cites this paper
• Vitamin D in Depression: A Potential Bioactive Agent to Reduce Suicide and Suicide Attempt Risk

  2023cites this paper
• Antidepressant Effect of Alpha Lipoic Acid in Rats Exposed to Chronic Unpredictable Mild Stress: Putative Role of Neurotransmitters and 5HT3 Receptor

  2023cites this paper
• Bidirectional Relationship Between Sleep and Depression.

  2023cites this paper
• Pharmacological evidence for glutamatergic pathway involvement in the antidepressant-like effects of 2-phenyl-3-(phenylselanyl)benzofuran in male Swiss mice

  2023cites this paper
• Ferulic acid as a therapeutic agent in depression: Evidence from preclinical studies

  2023cites this paper
• Antidepressant-like Effect of 1-(2-(4-(4-Ethylphenyl)-1H-1,2,3-triazol-1-yl)phenyl)ethan-1-one in Mice: Evidence of the Contribution of the Serotonergic System.

  2023cites this paper
• Treating depression in clinical practice: new insights on the multidisciplinary use of trazodone

  2023cites this paper
• Exploring the Relationship between Mood Disorders and Coexisting Health Conditions: The Focus on Nutraceuticals

  2023cites this paper
• Research Progress on the Antidepressant Effects of Baicalin and Its Aglycone Baicalein: A Systematic Review of the Biological Mechanisms

  2023cites this paper
• Changes in Adipokine, Resitin, and BDNF Concentrations in Treatment-Resistant Depression after Electroconvulsive Therapy

  2023cites this paper
• The Effects of Chronic Unpredictable Mild Stress and Semi-Pure Diets on the Brain, Gut and Adrenal Medulla in C57BL6 Mice

  2023cites this paper
• Evidencias y perspectivas del potencial antidepresivo del “alcaloide mágico” psilocibina: una revisión narrativa

  2023cites this paper
• Natural products for the treatment of depression: Insights into signal pathways influencing the hypothalamic–pituitary–adrenal axis

  2023cites this paper
• Inhaled Litsea glaucescens K. (Lauraceae) leaves' essential oil has anxiolytic and antidepressant-like activity in mice by BDNF pathway activation.

  2023cites this paper
• 睡眠剥夺对海马区单胺类神经递质、氨基酸代谢及小鼠行为的影响

  2023cites this paper
• Obesity and Depression. Some Neurochemical and Molecular Links

  2023cites this paper
• The monoamine theory of depression as a target to effective pharmacotherapy

  2023influential citation
• C-Reactive Protein as a Biomarker for Major Depressive Disorder?

  2022cites this paper
• Depression Pathophysiology: Astrocyte Mitochondrial Melatonergic Pathway as Crucial Hub

  2022cites this paper
• Reviewing the role of gut microbiota in the pathogenesis of depression and exploring new therapeutic options

  2022cites this paper
• Involvement of oxidative pathways and BDNF in the antidepressant effect of carvedilol in a depression model induced by chronic unpredictable stress

  2022cites this paper
• Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic review

  2022cites this paper